SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Guardant Health’s Shield colorectal test covered in Carelon guidelines from Nov. 15

Guardant Health said its Shield™ blood test for colorectal cancer screening will be covered in Carelon Healthcare Services clinical guidelines effective November 15.

GH
SquawkNews Desk

Guardant Health, Inc. said its Shield blood test for colorectal cancer screening will be covered in Carelon Healthcare Services clinical guidelines effective November 15. Carelon Healthcare Services is one of the largest specialty healthcare service companies.

Related stories

Hoban Group Becomes Hanjin KAL’s Largest Shareholder M impact | EQUITY | Nov 02, 2026, 08:39 AM UTC Sempio and Sempio Foods Hit Daily Price Limits Shares of Sempio and Sempio Foods both hit their daily upper price limits amid news of efforts to resolve their overlapping listings. M impact | EQUITY | Nov 02, 2026, 08:38 AM UTC SK Square to Return 70% of SK hynix Dividend Income to Shareholders SK Square plans to return 70% of dividend income from SK hynix to shareholders. L impact | EQUITY | Nov 02, 2026, 08:38 AM UTC SNDR Reports Fiscal Q3 Profit Up 46.75% SNDR reported fiscal 2026 third-quarter profit attributable to shareholders up 46.75% year over year, with basic EPS also reported. M impact | EQUITY | Nov 02, 2026, 08:38 AM UTC WHD Reports Fiscal Q3 Profit Up 14.18% WHD reported fiscal third-quarter profit attributable to shareholders of 1.441亿美元, up 14.18% year over year, with basic EPS of 0.9美元. M impact | EQUITY | Nov 02, 2026, 08:38 AM UTC Ryanair Q2 Profit Falls 6% on Lower Fares and Higher Fuel Costs Ryanair Holdings reported that second-quarter profit fell 6%, citing lower fares and higher fuel costs. M impact | EQUITY | Nov 02, 2026, 08:37 AM UTC